LifebankUSA(TM) Announces New Service to Bank Placental-Derived Stem Cells

20-Apr-2006

LifebankUSA, a subsidiary of Celgene Cellular Therapeutics (CCT), announced plans for a new service to bank stem cells derived from the placenta. Placental-derived stem cells (PDSCs), which have different characteristics from those isolated from cord blood, appear to be highly versatile and have the potential to repair damaged or diseased tissue. In the laboratory, CCT scientists have successfully developed nerve cells, heart cells, cartilage cells, bone cells, and other highly specialized cells from pluripotent stem cells derived from the placenta.

The new Placental-Derived Stem Cell Storage Service will begin on April 24th.

Other news from the department research and development

Most read news

More news from our other portals

Fighting cancer: latest developments and advances